Which mutual funds hold both JB Chemicals & Pharmaceuticals and Vijaya Diagnostic Centre?

27 funds hold both; the largest combined position is Nippon India Pharma Fund, as on May 2026. Information only, not investment advice.

Compare stocks

Stock co-ownership

Mutual funds holding both JB Chemicals & Pharmaceuticals and Vijaya Diagnostic Centre

27 funds hold both · as on May 2026

Hold both

Hold JB

JB Chemicals & Pharmaceuticals

Hold Vijaya

Vijaya Diagnostic Centre

Co-Ownership Analysis

Comparing mutual fund co-ownership helps identify hidden asset concentration. Our reverse lookup database shows that 27 mutual funds hold active equity positions in both JB Chemicals & Pharmaceuticals and Vijaya Diagnostic Centre. The scheme with the highest combined exposure is Nippon India Pharma Fund (Nippon India MF), which holds a 3.70% stake in JB Chemicals & Pharmaceuticals and a 3.10% stake in Vijaya Diagnostic Centre, amounting to a combined conviction weight of 6.80%.

When multiple mutual funds in your portfolio double-up on the same stock pairs, it limits your diversification benefits. If you also hold either of these companies directly in your demat account, your aggregate exposure is amplified. This co-ownership pattern is standard among index-tracking products but represents active, concentrated strategies in equity schemes.

Funds holding both

Fund	JB wt.	Vijaya wt.	Combined
Nippon India Pharma FundNippon India MF · Sectoral / Thematic	3.70%	3.10%	6.80%
Aditya Birla Sun Life Pharma & Healthcare FundAditya Birla SL MF · Sectoral / Thematic	4.71%	0.98%	5.69%
Kotak Small Cap FundKotak MF · Small Cap	0.87%	4.04%	4.91%
Tata India Pharma & Healthcare FundTata MF · Sectoral / Thematic	2.24%	1.14%	3.38%
ICICI Prudential Quality FundICICI Pru MF · Smart-Beta / Factor	1.91%	1.20%	3.11%
Tata India Innovation FundTata MF · Sectoral / Thematic	1.32%	0.92%	2.24%
Nippon India Flexi Cap FundNippon India MF · Flexi Cap	1.48%	0.49%	1.97%
Back to IndexMotilal Oswal MF · Index Fund	1.22%	0.39%	1.61%
Nippon India Multi Cap FundNippon India MF · Multi Cap	0.59%	0.62%	1.21%
Kotak Nifty Smallcap 250 Index FundKotak MF · Index Fund	0.88%	0.32%	1.20%
SBI Nifty Small Cap 250 ETFSBI MF · ETF	0.88%	0.32%	1.20%
SBI Nifty Smallcap 250 Index FundSBI MF · Index Fund	0.88%	0.32%	1.20%
ICICI Prudential Nifty Smallcap 250 Index FundICICI Pru MF · Index Fund	0.88%	0.32%	1.19%
DSP Nifty Smallcap 250 ETFDSP MF · ETF	0.88%	0.31%	1.19%
DSP Nifty Smallcap 250 Index FundDSP MF · Index Fund	0.87%	0.32%	1.19%
Back to IndexMotilal Oswal MF · Index Fund	0.84%	0.28%	1.12%
Back to IndexMotilal Oswal MF · Index Fund	0.84%	0.28%	1.12%
Nippon India Nifty Smallcap 250 Index FundNippon India MF · Index Fund	0.85%	0.20%	1.05%
IB52-Groww Nifty Smallcap 250 ETFGroww MF · ETF	0.66%	0.23%	0.89%
IB20-Groww Nifty Smallcap 250 Index FundGroww MF · Index Fund	0.66%	0.23%	0.89%
ICICI Prudential Nifty 500 Index FundICICI Pru MF · Index Fund	0.09%	0.03%	0.12%
Back to IndexMotilal Oswal MF · Index Fund	0.09%	0.03%	0.12%
Back to IndexMotilal Oswal MF · Index Fund	0.09%	0.03%	0.12%
Back to IndexMotilal Oswal MF · Index Fund	0.09%	0.03%	0.12%
DSP Nifty 500 Index FundDSP MF · Index Fund	0.09%	0.03%	0.12%
SBI Nifty 500 Index FundSBI MF · Index Fund	0.09%	0.03%	0.12%
IB18-Groww Nifty Total Market Index FundGroww MF · Index Fund	0.07%	0.02%	0.09%

FAQ

Which mutual funds hold both JB Chemicals & Pharmaceuticals and Vijaya Diagnostic Centre?: 27 funds hold both; the largest combined position is Nippon India Pharma Fund, as on May 2026. Information only, not investment advice.
How many funds hold JB Chemicals & Pharmaceuticals and Vijaya Diagnostic Centre individually?: In our coverage, 56 funds hold JB Chemicals & Pharmaceuticals and 40 hold Vijaya Diagnostic Centre; 27 hold both.

Related comparisons

Check fund overlap too?

These funds hold both stocks — see how much their entire portfolios overlap.

Check overlap of top funds →

“Holds both” = the fund discloses an equity position in each stock in its latest public monthly portfolio (as on May 2026). Weight = the position as a % of that fund's portfolio. ISIN-verified from AMC disclosures. Not investment advice.